Literature DB >> 24259350

F-wave latencies in patients with diabetes mellitus.

Hua Pan1, Fan Jian, Jinxi Lin, Na Chen, Chunfang Zhang, Zaiqiang Zhang, Zeyu Ding, Yongjun Wang, Liying Cui, Jun Kimura.   

Abstract

INTRODUCTION: To evaluate the sensitivity of electrophysiologic assessments, we compared F-waves and motor and sensory nerve conduction studies (MNCS and SNCS) in patients with diabetes mellitus (DM).
METHODS: We tested median, ulnar, tibial, and fibular nerves in 132 DM patients divided into those with and without clinical evidence of polyneuropathy.
RESULTS: Of 64 asymptomatic patients, 2 (3%) had MNCS or SNCS abnormalities, both of whom had F-wave changes, whereas 21 (33%) had only delayed F-waves, for a combined yield of 23 (36%). The corresponding values for 68 symptomatic patients consisted of 43 (63%), 14 (21%), and 57 (84%). In both groups, F-wave latency had a higher (P<0.05) frequency of abnormality than MNCS in all nerves. F-wave study also surpassed SNCS in lower limb nerves.
CONCLUSIONS: F-waves of the tibial and fibular nerves are the most sensitive measure to detect subclinical or overt diabetic polyneuropathy. Muscle Nerve 49: 804-808, 2014.
Copyright © 2013 Wiley Periodicals, Inc.

Entities:  

Keywords:  F-wave; diabetes mellitus; diabetic polyneuropathy; height-latency nomogram; nerve conduction study

Mesh:

Year:  2014        PMID: 24259350     DOI: 10.1002/mus.24127

Source DB:  PubMed          Journal:  Muscle Nerve        ISSN: 0148-639X            Impact factor:   3.217


  7 in total

1.  Morphological changes of the peripheral nerves evaluated by high-resolution ultrasonography are associated with the severity of diabetic neuropathy, but not corneal nerve fiber pathology in patients with type 2 diabetes.

Authors:  Fukashi Ishibashi; Miki Taniguchi; Rie Kojima; Asami Kawasaki; Aiko Kosaka; Harumi Uetake
Journal:  J Diabetes Investig       Date:  2014-11-27       Impact factor: 4.232

2.  Association of peripheral nerve conduction in diabetic neuropathy with subclinical left ventricular systolic dysfunction.

Authors:  Yasuhide Mochizuki; Hidekazu Tanaka; Kensuke Matsumoto; Hiroyuki Sano; Hiromi Toki; Hiroyuki Shimoura; Junichi Ooka; Takuma Sawa; Yoshiki Motoji; Keiko Ryo; Yushi Hirota; Wataru Ogawa; Ken-ichi Hirata
Journal:  Cardiovasc Diabetol       Date:  2015-05-07       Impact factor: 9.951

3.  Relationship between the Diabetic Polyneuropathy Index and the Neurological Findings of Diabetic Polyneuropathy.

Authors:  Shoji Hemmi; Katsumi Kurokawa; Taiji Nagai; Keiichi Yokoi; Toshio Okamoto; Akio Asano; Tatsufumi Murakami; Masahito Mihara; Yoshihide Sunada
Journal:  Intern Med       Date:  2020-05-23       Impact factor: 1.271

4.  The Physiological Significance of A-Waves in Early Diabetic Neuropathy: Assessment of Motor Nerve Fibers by Neurophysiological Techniques.

Authors:  Qiong Cai; Guliqiemu Aimair; Wen-Xiao Xu; Pei-Yao Xiao; Lie-Hua Liu; Yin-Xing Liang; Chao Wu; Song-Jie Liao
Journal:  Front Syst Neurosci       Date:  2021-01-28

5.  Standard Clinical Screening Tests, Sural Radial Amplitude Ratio and F Wave Latency Compared to Conventional Nerve Conduction Studies in the Assessment of Sensorimotor Polyneuropathy in Patients with Type 2 Diabetes Mellitus.

Authors:  Saraswathi Ramanathan; Raji Thomas; Asem Rangita Chanu; Dukhabandu Naik; Felix Jebasingh; Ajit Sivadasan; Nihal Thomas
Journal:  Indian J Endocrinol Metab       Date:  2022-02-17

6.  Diabetic Distal Symmetrical Polyneuropathy: Correlation of Clinical, Laboratory, and Electrophysiologic Studies in Patients with Type 2 Diabetes Mellitus.

Authors:  Yi-Ching Weng; Sung-Sheng Tsai; Rong-Kuo Lyu; Chun-Che Chu; Long-Sun Ro; Ming-Feng Liao; Hong-Shiu Chang; Chiung-Mei Chen; Jawl-Shan Hwang; Hung-Chou Kuo
Journal:  J Diabetes Res       Date:  2020-07-03       Impact factor: 4.011

Review 7.  Lumos for the long trail: Strategies for clinical diagnosis and severity staging for diabetic polyneuropathy and future directions.

Authors:  Tatsuhito Himeno; Hideki Kamiya; Jiro Nakamura
Journal:  J Diabetes Investig       Date:  2019-12-01       Impact factor: 4.232

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.